AI companies such as OpenAI and Anthropic have long focused on building tools that can write code that will speed up software ...

C compiler, LustreC, into a generator of both executable code and associated specification. Model-based design tools are ...

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

1. Risk: AI Monoculture (Shared Blind Spots). This is the most critical and overlooked systemic vulnerability. Building your ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Palantir has been one of the best growth stories in the market. UiPath is just beginning to see its revenue growth accelerate ...

2026 Market Outlook: The S&P 500 ( SPX) has been on a roll over the past several years, led primarily by the boom in optimism over AI, with stocks like Nvidia ( NVDA ), Meta Platforms ( META ), and ...

This study presents a valuable advance in reconstructing naturalistic speech from intracranial ECoG data using a dual-pathway model. The evidence supporting the claims of the authors is solid, ...